REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Amigpharm S.A. (Ecuador)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Amigpharm S.A. Profile Updated: March 09, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English & Spanish Download a sample report

Amigpharm S.A. is based in Ecuador. The head office is in Cuenca. The company operates in the Pharmaceutical and Medicine Manufacturing industry. Amigpharm S.A. was incorporated on January 05, 2011. It currently has a total number of 4 (2024) employees. From the latest financial highlights, Amigpharm S.A. reported a net sales revenue increase of 40.3% in 2025. Over the same period, its total assets grew by 40.4%. The enterprise’s net profit margin increased by 10.42% in 2025.

Headquarters
Av. 10 de Agosto, 32-74
Cuenca; Azuay;

Contact Details: Purchase the Amigpharm S.A. report to view the information.

Basic Information
Total Employees:
Purchase the Amigpharm S.A. report to view the information.
Registered Capital:
Purchase the Amigpharm S.A. report to view the information.
Financial Auditors:
Purchase the Amigpharm S.A. report to view the information.
Incorporation Date:
January 05, 2011
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
Manager
Ownership Details
Purchase this report to view the information.
75%
Purchase this report to view the information.
12.5%
Purchase this report to view the information.
12.5%
Company Performance
Financial values in the chart are available after Amigpharm S.A. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
40.3%▲
Total Operating Revenue
40.3%▲
Operating Profit
337.43%▲
EBITDA
327.78%▲
Net Profit/Loss for the Period
227.71%▲
Total Assets
40.4%▲
Total Equity
N/A
Operating Profit Margin
21.21%▲
Net Profit Margin
10.42%▲
Return on Equity (ROE)
N/A
Quick Ratio
0.57%▲

Similar companies

Quifatex Sa
 
Laboratorios Siegfried S.A.
Roche Ecuador S.A.
 
Bayer S.A.
Nefrocontrol S.A.
 
Novartis Ecuador S.A.
Phytoworld Cia. Ltda
 
Distribuidora Smart Remedy Smareme S.A.
Eli Lilly Interamerica Inc.
 
Compania Servimed Asr Cia. Ltda
Laboprep S.A.S.
 

Related EMIS Industry Reports

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo